These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7497931)

  • 1. [Can virus safety of blood products be assured?].
    Krusius T
    Duodecim; 1994; 110(13):1227-30. PubMed ID: 7497931
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy with blood and blood products].
    Kreienbühl G
    Urologe A; 1996 Jan; 35(1):69-85. PubMed ID: 8851853
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond HIV, HBV and HCV--how to deal with other viruses?
    Minor PD
    Dev Biol (Basel); 2002; 108():15-9. PubMed ID: 12220138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood transfusion safety].
    Koistinen J
    Duodecim; 2004; 120(7):902-4. PubMed ID: 15154312
    [No Abstract]   [Full Text] [Related]  

  • 5. [Transfusion medicine--Scandinavian recommendations].
    Jørgensen J; Jensson O; Eklund J; Kornstad L; Messeter L
    Nord Med; 1994; 109(2):61-3. PubMed ID: 8121792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-borne viral infections.
    Gürtler L
    Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 3():S5-10; discussion S11-2. PubMed ID: 7749048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood - surely but safely!].
    Offergeld R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Aug; 55(8):905-6. PubMed ID: 22842882
    [No Abstract]   [Full Text] [Related]  

  • 8. [Patient information and follow-up of transfusions: "a checked report"?].
    Jullian H; Fuentes AM; Colavolpe JC; Gentille S
    Ann Fr Anesth Reanim; 1999 Apr; 18(4):fi60-3. PubMed ID: 10365217
    [No Abstract]   [Full Text] [Related]  

  • 9. [Transfusion medicine in unified Europe].
    Grigutsch V
    Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():12-5. PubMed ID: 7841774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety of blood transfusions; need for 'hemo-vigilance'].
    van Aken WG; van Rood JJ
    Ned Tijdschr Geneeskd; 1998 Feb; 142(6):281-4. PubMed ID: 9562726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of pathogens in blood and blood products.
    Ben-Hur E
    Med Health R I; 1998 Dec; 81(12):396-9. PubMed ID: 9884539
    [No Abstract]   [Full Text] [Related]  

  • 12. [Costs of safety of blood and blood products].
    Seifried E; Soedel G
    Zentralbl Chir; 1995; 120(8):584-92. PubMed ID: 7571889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogen inactivation of labile blood products.
    Council of Europe Expert Committee in Blood Transfusion Study Group on Pathogen Inactivation of Labile Blood Components
    Transfus Med; 2001 Jun; 11(3):149-75. PubMed ID: 11422945
    [No Abstract]   [Full Text] [Related]  

  • 14. What is safe blood?
    Kapoor D; Sarin SK
    J Assoc Physicians India; 2000 Mar; 48(3):335-42. PubMed ID: 11229123
    [No Abstract]   [Full Text] [Related]  

  • 15. [Infections as complications of blood transfusion]].
    Kłos M
    Przegl Epidemiol; 2001; 55 Suppl 3():4-9. PubMed ID: 11984956
    [No Abstract]   [Full Text] [Related]  

  • 16. [Quality assurance management system for therapy with blood and blood products].
    Diekamp U
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Oct; 33(10):664-5. PubMed ID: 9825053
    [No Abstract]   [Full Text] [Related]  

  • 17. [Virologic aspects of blood and plasma product safety].
    Gärtner BC; Mueller-Lantzsch N
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Aug; 34(8):486-8. PubMed ID: 10494367
    [No Abstract]   [Full Text] [Related]  

  • 18. [XMRV is not pathogenic in human and has no significance for the safety of blood and blood products].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Aug; 55(8):1057-60. PubMed ID: 22842897
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines on the clinical use of leucocyte-depleted blood components. British Committee for Standards in Haematology, Blood Transfusion Task Force.
    Transfus Med; 1998 Mar; 8(1):59-71. PubMed ID: 9569462
    [No Abstract]   [Full Text] [Related]  

  • 20. Status of NAT screening for HCV, HIV and HBV--experiences of the German Red Cross Blood Donation Services.
    Seifried E; Findhammer S; Roth WK
    Dev Biol (Basel); 2002; 108():23-7. PubMed ID: 12220139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.